WHITE PAPER
The Cost of the 340B Program Part 1: Self-Insured Employers
Mar 12, 2024

At first glance, the financial behavior of the 340 program appears to be simple: 340B hospitals and clinics benefit, manufacturers pay, and the narrative is the program does not cost taxpayers anything. To test these assumptions, IQVIA created a model to quantify the financial impact of the 340B program on drug and total healthcare costs. Explore the findings of IQVIA's study to understand the impact on self-insured employers and the 100+ million workers they employ.

Read part 2 here.

Contact Us